← Latest news 
Cohance Lifesciences shares jump 20% after naming former Cipla CEO Umang Vohra as boss
Business
Published on 27 April 2026

The new chairman is a Cipla veteran
Cohance Lifesciences shares surged 20% on Monday after appointing former Cipla CEO Umang Vohra as Executive Chairman and Group CEO. The company expects his leadership to push transformation, expand operations, and deepen global partnerships as it moves into a new growth phase. Investors reacted sharply to the change at the top.
- Cohance Lifesciences shares rose 20% after appointing Umang Vohra
- Vohra takes charge as Executive Chairman and Group CEO
- Company cites transformation, scaling operations, and global partnerships
Read the full story at The Economic Times
This summarization was done by Beige for a story published on
The Economic Times
